A case of transcatheter prosthetic aortic valve endocarditis
Transcatheter aortic valve implantation (TAVR) constitutes an established treatment in inoperable or high perioperative risk patients with severe aortic stenosis. Prosthetic valve endocarditis after ΤΑVR occurs with an incidence of 0.3–1% per patient-year. Infective endocarditis may stem from hemato...
Main Authors: | Muhammad Shabbir Rawala, Amna Saleem Ahmed, Syed Bilal Rizvi, Aravinda Nanjundappa |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-05-01
|
Series: | Journal of Community Hospital Internal Medicine Perspectives |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/20009666.2020.1766801 |
Similar Items
-
Endocarditis in Patients with Aortic Valve Prosthesis: Comparison between Surgical and Transcatheter Prosthesis
by: Micaela De Palo, et al.
Published: (2021-01-01) -
Repeat Transcatheter Aortic Valve Replacement and Follow-Up of Embolized Transcatheter Heart Valve After 13 Years
by: Abdul Rahman Ihdayhid, MBBS, PhD, et al.
Published: (2021-04-01) -
Periprocedural considerations of transcatheter aortic valve implantation for anesthesiologists
by: Ata Hassani Afshar, et al.
Published: (2016-06-01) -
Transcatheter, valve-in-valve transapical aortic and mitral valve implantation, in a high risk patient with aortic and mitral prosthetic valve stenoses
by: Harish Ramakrishna, et al.
Published: (2015-01-01) -
Editorial: Transcatheter Aortic Valve Implantation—Current Challenges and Future Directions
by: Richard J. Jabbour, et al.
Published: (2021-09-01)